The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Drug discovery and development for neglected parasitic diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Cysteine proteases of parasitic organisms
Sajid, M., & McKerrow, J. H. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00438-8 · Cited by 794
Self-citationFeatures of Selective Kinase Inhibitors
Knight, Z. A., & Shokat, K. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.011 · Cited by 657
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Opperdoes, F. R., & Borst, P. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80476-6 · Cited by 600
A Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides
O'Neill, P. M., & Posner, G. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030571c · Cited by 538
History of the development of azole derivatives
Maertens, J. A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00841.x · Cited by 475
Du, X., Guo, C., Hansell, E., Doyle, P. S., Caffrey, C. R., Holler, T. P., McKerrow, J. H., & Cohen, F. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010459j · Cited by 381
Self-citationA clinical drug library screen identifies astemizole as an antimalarial agent
Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio806 · Cited by 289
Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor
Abdulla, M.-H., Lim, K.-C., Sajid, M., McKerrow, J. H., & Caffrey, C. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040014 · Cited by 269
Self-citationEggleson, K. K., Duffin, K. L., & Goldberg, D. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32411 · Cited by 267
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class
Haynes, R. K., Fugmann, B., Stetter, J., Rieckmann, K., Heilmann, H., Chan, H., Cheung, M., Lam, W., Wong, H., Croft, S. L., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503071 · Cited by 260
Biological Roles of Proteases in Parasitic Protozoa
Klemba, M., & Goldberg, D. E. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.090501.145453 · Cited by 248
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Antimalarial Activity of Artemisinin (Qinghaosu) and Related Trioxanes: Mechanism (s) of Action
(1996) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60952-7 · Cited by 241
Ras Farnesyltransferase: A New Therapeutic Target
Leonard, D. M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970226l · Cited by 241
Glycolysis as a target for the design of new anti-trypanosome drugs
Verlinde, C. L. M. J., Hannaert, V., Blonski, C., Willson, M., Périé, J. J., Fothergill‐Gilmore, L. A., Opperdoes, F. R., Gelb, M. H., Hol, W. G. J., & Michels, P. A. M. (2001) · Drug Resistance Updates · doi:10.1054/drup.2000.0177 · Cited by 240
Ornithine decarboxylase as an enzyme target for therapy
McCann, P. P., & Pegg, A. E. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90032-u · Cited by 235
Protein kinases as drug targets in trypanosomes and Leishmania
Naula, C., Parsons, M., & Mottram, J. C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.018 · Cited by 228
Bogyo, M., Verhelst, S., Bellingard-Dubouchaud, V., Toba, S., & Greenbaum, D. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00061-2 · Cited by 217
THE MECHANISMS OF TRYPANOSOMA CRUZI INVASION OF MAMMALIAN CELLS
Burleigh, B. A., & Andrews, N. W. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.001135 · Cited by 209
Structure of and kinetic channelling in bifunctional dihydrofolate reductase–thymidylate synthase
Knighton, D. R., Kan, C.-C., Howland, E., Janson, C. A., Hostomska, Z., Welsh, K. M., & Matthews, D. A. (1994) · Nature Structural Biology · doi:10.1038/nsb0394-186 · Cited by 196
Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
Selzer, P. M., Pingel, S., Hsieh, I., Ugele, B., Chan, V. J., Engel, J. C., Bogyo, M., Russell, D. G., Sakanari, J. A., & McKerrow, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11015 · Cited by 195
Self-citationTherapeutic intervention based on protein prenylation and associated modifications
Gelb, M. H., Brunsveld, L., Hrycyna, C. A., Michaelis, S., Tamanoi, F., Van Voorhis, W. C., & Waldmann, H. (2006) · Nature Chemical Biology · doi:10.1038/nchembio818 · Cited by 194
Protein Farnesyltransferase Inhibitors Exhibit Potent Antimalarial Activity
Nallan, L., Bauer, K. D., Bendale, P., Rivas, K., Yokoyama, K., Hornéy, C. P., Pendyala, P. R., Floyd, D., Lombardo, L. J., Williams, D. K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0491039 · Cited by 177
Berman, J. D., Badaró, R. J. D. S., Thakur, C. P., Wasunna, K. M., Behbehani, K., Davidson, R. N., Kuzoe, F. A. S., Pang, L. W., Weerasuriya, K., & Bryceson, A. D. M. (1998) · Europe PMC (PubMed Central) · Cited by 171
Wu, Y. (2002) · Accounts of Chemical Research · doi:10.1021/ar000080b · Cited by 159
Haynes, R. K., Ho, W., Chan, H., Fugmann, B., Stetter, J., Croft, S. L., Vivas, L., Peters, W., & Robinson, B. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352343 · Cited by 148
Antimalarial Synergy of Cysteine and Aspartic Protease Inhibitors
Semenov, A., Olson, J. E., & Rosenthal, P. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2254 · Cited by 131
Synthesis and Antimalarial Activity of Novel Medium-Sized 1,2,4,5-Tetraoxacycloalkanes
Kim, H.-S., Nagai, Y., Ono, K., Begum, K., Wataya, Y., Hamada, Y., Tsuchiya, K., Masuyama, A., Nojima, M., & McCullough, K. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010026g · Cited by 128
Searching for New Antimalarial Therapeutics amongst Known Drugs
Weisman, J. L., Liou, A. P., Shelat, A. A., Cohen, F. E., Guy, R. K., & DeRisi, J. L. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00391.x · Cited by 127
Schistosome Calcium Channel β Subunits
Kohn, A. B., Anderson, P. A. V., ROBERTS-MISTERLY, J. M., & Greenberg, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100273200 · Cited by 125
Wasilewski, M. M., Lim, K. C., Phillips, J., & McKerrow, J. H. (1996) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(96)02703-x · Cited by 125
Self-citationTrypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
Hofer, A., Steverding, D., Chabes, A., Brun, R., & Thelander, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111139498 · Cited by 118
Eastman, R. T., C, F. S. B. A., Yokoyama, K., Gelb, M. H., & Voorhis, W. C. V. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500016-jlr200 · Cited by 118
Dong, Y., Chollet, J., Matile, H., Charman, S. A., Chiu, F. C. K., Charman, W. N., Scorneaux, B., Urwyler, H., Tomas, J. S., Scheurer, C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049040u · Cited by 117
Metabolic compartmentation in African trypanosomes
CLAYTON, C. E., & Michels, P. A. M. (1996) · Parasitology Today · doi:10.1016/s0169-4758(96)10073-9 · Cited by 110
Discovery of Trypanocidal Compounds by Whole Cell HTS of Trypanosoma brucei
Mackey, Z. B., Baca, A. M., Mallari, J. P., Apsel, B., Shelat, A. A., Hansell, E. J., Chiang, P. K., Wolff, B. E., Guy, R. K., Williams, J. A., et al. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00389.x · Cited by 106
Self-citationA Cathepsin B-like Protease Is Required for Host Protein Degradation in Trypanosoma brucei
Mackey, Z. B., O’Brien, T. C., Greenbaum, D. C., Blank, R. B., & McKerrow, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402470200 · Cited by 105
Self-citationGuedes, P. M. D. M., Urbina, J. A., de Lana, M., Afonso, L., Veloso, V. M., Tafuri, W. L., Machado-Coelho, G. L. L., Chiari, É., & Bahia, M. T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4286-4292.2004 · Cited by 86
Posner, G. H., Parker, M. H., Northrop, J. P., Elias, J. S., Ploypradith, P., Xie, S., & Shapiro, T. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980529v · Cited by 86
Salter, J. P., Choe, Y., Albrecht, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202364200 · Cited by 84
Vennerstrom, J. L., Dong, Y., Andersen, S. L., Ager, A. L., Fu, H., Miller, R. E., WESCHE, D. L., Kyle, D. E., Gerena, L., Walters, S. M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000766 · Cited by 84
Madrid, P. B., Liou, A. P., DeRisi, J. L., & Guy, R. K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600951 · Cited by 82
Second-generation azole antifungal agents
Kale-Pradhan, P. B., & Johnson, L. B. (2005) · Drugs of today · doi:10.1358/dot.2005.41.2.882661 · Cited by 82
Bachi, M. D., Korshin, E. E., Hoos, R., Szpilman, A. M., Ploypradith, P., Xie, S., Shapiro, T. A., & Posner, G. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020584a · Cited by 77
Validating targets for antiparasite chemotherapy
Wang, C. (1997) · Parasitology · doi:10.1017/s0031182097001017 · Cited by 74
Induction of Resistance to Azole Drugs in Trypanosoma cruzi
C, F. S. B. A., Wilson, A. J., White, T. C., & Voorhis, W. C. V. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3245 · Cited by 74
Medicines for Malaria Venture: sustaining antimalarial drug development
Bathurst, I., & Hentschel, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.05.011 · Cited by 72
Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase
Zuccotto, F., Zvelebil, M., Brun, R., Chowdhury, S. F., Lucrezia, R. D., Leal, I., Maes, L. J. R. M., Ruiz-Pérez, L. M., González‐Pacanowska, D., & Gilbert, I. H. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01235-1 · Cited by 70
Szpilman, A. M., Korshin, E. E., Rozenberg, H., et al. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050074z · Cited by 66
Liposomal amphotericin B: clinical experience and perspectives
Gibbs, W. J., Drew, R. H., & Perfect, J. R. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.2.167 · Cited by 60
Design and Synthesis of Endoperoxide Antimalarial Prodrug Models
O’Neill, P. M., Stocks, P. A., Pugh, M. D., Araújo, N., Korshin, E. E., Bickley, J. F., Ward, S. A., Bray, P. G., Pasini, E. M., Davies, J. D., et al. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200453859 · Cited by 60
O’Neill, P. M., Searle, N. L., Kan, K.-W., Storr, R. C., Maggs, J. L., Ward, S. A., Raynes, K. J., & Park, B. K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903545 · Cited by 58
Posner, G. H., Cumming, J. N., Woo, S.-H., Ploypradith, P., Xie, S., & Shapiro, T. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970686e · Cited by 57
Antimalarial Cyclic Peroxy Ketals
Posner, G. H., O’Dowd, H., Ploypradith, P., Cumming, J. N., Xie, S., & Shapiro, T. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980088f · Cited by 56
O’Neill, P. M., Rawe, S. L., Borstnik, K., Miller, A., Ward, S. A., Bray, P. G., Davies, J. D., Oh, C. H., & Posner, G. H. (2005) · ChemBioChem · doi:10.1002/cbic.200500048 · Cited by 54
Sturk, L. M., Brock, J. L., Bagnell, C. R., Hall, J. E., & Tidwell, R. R. (2004) · Acta Tropica · doi:10.1016/j.actatropica.2004.03.010 · Cited by 46
Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity.
Hofheinz, W., Bürgin, H., Gocke, E., Jaquet, C., Masciadri, R., Schmid, G., Stohler, H. R., & Urwyler, H. (1994) · PubMed · Cited by 40
Glenn, M., Chang, S.-Y., Hornéy, C., Rivas, K. L., Yokoyama, K., Pusateri, E. E., Fletcher, S., Cummings, C., Buckner, F., Pendyala, P. R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060081v · Cited by 38
Haynes, R. K., Chan, H., Ho, W., Ko, C. K., Gerena, L., Kyle, D. E., Peters, W., & Robinson, B. L. (2005) · ChemBioChem · doi:10.1002/cbic.200400366 · Cited by 38
Trypanosomal dUTPases as Potential Targets for Drug Design
Hidalgo‐Zarco, F., & González‐Pacanowska, D. (2001) · Current Protein and Peptide Science · doi:10.2174/1389203013381026 · Cited by 30
Hankins, E. G., Gillespie, J. R., Aikenhead, K., et al. (2005) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.08.002 · Cited by 28
Cited by
Control of Neglected Tropical Diseases
Hotez, P. J., Molyneux, D. H., Fenwick, A., Kumaresan, J., Sachs, S. E., Sachs, J. D., & Savioli, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064142 · Cited by 1,585
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700139 · Cited by 709
Kinetoplastids: related protozoan pathogens, different diseases
Stuart, K., Brun, R., Croft, S., Fairlamb, A., Gürtler, R. E., McKerrow, J., Reed, S., & Tarleton, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33945 · Cited by 604
Self-citationNerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities
Chan, W.-K., Tan, L., Chan, K.-G., Lee, L.-H., & Goh, B.-H. (2016) · Molecules · doi:10.3390/molecules21050529 · Cited by 477
Biologically active quinoline and quinazoline alkaloids part I
Shang, X., Morris‐Natschke, S. L., Liu, Y., Guo, X., Xu, X., Goto, M., Li, J., Yang, G., & Lee, K. (2018) · Medicinal Research Reviews · doi:10.1002/med.21466 · Cited by 437
Metadata
- Authors
- Renslo, A. R., & McKerrow, J. H.
- Venue
- Nature Chemical Biology
- Published
- 2006-12
- Volume
- 2
- Issue
- 12
- Pages
- 701-710
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W1989266032
- Cited by
- 337
- References
- 65
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.